Search

Displaying results 831 - 840 of 8573 in total
  1. Drug

    Cimetidine

    go.drugbank.com/drugs/DB00501
    ApprovedInvestigational

    Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrins output.

    Products: Tagamet Inj 150mg/ml, Peptol Tab 200mg
  2. Drug

    Naproxen

    go.drugbank.com/drugs/DB00788
    ApprovedInvestigationalVet approved

    [A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile. … Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.

    Mixtures: VIMOVO 500MG/20MG MODIFIED-RELEASE TABLETSProducts: INFOR® 100MG, APRONAX TABLETAS LACADAS 100MG
  3. Drug

    Sodium ascorbate

    go.drugbank.com/drugs/DB14482
    ApprovedInvestigationalNutraceutical

    Mixtures: Virt-Bal DHA Plus, Vitamin C Tab 100mgProducts: C Wafer 500 Chewable 500mg
  4. Target

    BAG family molecular chaperone regulator 1

    go.drugbank.com/bio_entities/BE0003774
    TargetHumans

    Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release. Nucleotide release is med...

    Polypeptides: BAG family molecular chaperone regulator 1Synonyms: BAG-1
  5. Drug

    Voriconazole

    go.drugbank.com/drugs/DB00582
    ApprovedInvestigational

    [A236050] Voriconazole was approved by the FDA under the trade name Vfend on May 24, 2002.[L34660]

    Products: VORICONAZOL ARISTO 100MG, VFEND 200MG
  6. Drug

    Tenofovir alafenamide

    go.drugbank.com/drugs/DB09299
    ApprovedInvestigational

    [A178219] It has been reported to produce a large antiviral efficacy at doses ten times lower than tenofovir disoproxil. … [L4388,L9010] Tenofovir alafenamide was developed by Gilead Sciences Inc and granted FDA approval on 5 November 2015.[L6271]

    Mixtures: GENVOYA 150MG/150MG/200MG/10MG FILM KAPLI TABLET, 90 ADET, GENVOYA 150MG/150MG/200MG/10MG FILM KAPLI TABLET, 30 ADET
  7. Drug

    Icosapent

    go.drugbank.com/drugs/DB00159
    ApprovedInvestigationalNutraceutical

    It serves as the precursor for the prostaglandin-3 and thromboxane-3 families.

    Mixtures: Virt-Bal DHA Plus, SANTAFER FORT 100MG/0,35 MG FILM KAPLI TABLET, 30 ADET
  8. Indication

    Acid Base Imbalance

    go.drugbank.com/conditions/DBCOND0046840
    Drugs: Sodium phosphate, monobasic
    Synonyms: Acid-Base Imbalance, Acid Base Imbalance
  9. Drug

    Mocravimod

    go.drugbank.com/drugs/DB18151
    Investigational

    Synonyms: Krp-203 free base
  10. Drug

    Elvitegravir

    go.drugbank.com/drugs/DB09101
    ApprovedInvestigational

    Elvitegravir was first licensed from Japan Tobacco in 2008 and developed by Gilead Sciences. It was FDA approved on August 27, 2012. … Although available as a single dose tablet, elvitegravir must be used in combination with an HIV protease inhibitor coadministered with ritonavir and another antiretroviral drug.

    Mixtures: GENVOYA 150MG/150MG/200MG/10MG FILM KAPLI TABLET, 90 ADET, GENVOYA 150MG/150MG/200MG/10MG FILM KAPLI TABLET, 30 ADET